Mallén, A., Rotllan, N., Griñán, R., Varela, C., Bertolino, E., Paloschi, V., . . . Hueso, M. (2026). In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis.
Citación estilo ChicagoMallén, A., et al. In Vivo Inhibition of MiR-125b-5p Modulates Monocyte Trafficking Through the CCR7 Receptor and Reduces Atherosclerosis. 2026.
Cita MLAMallén, A., et al. In Vivo Inhibition of MiR-125b-5p Modulates Monocyte Trafficking Through the CCR7 Receptor and Reduces Atherosclerosis. 2026.
Precaución: Estas citas no son 100% exactas.